ORIGINAL ARTICLE. Abstract. Introduction
|
|
- Jocelyn Chambers
- 5 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE Prevalence and Characteristics of Headaches in a Socially Active Population Working in the Tokyo Metropolitan Area Surveillance by an Industrial Health Consortium Norihiro Suzuki 1, Yoshiki Ishikawa 2, Shintaro Gomi 3, Nobuhiko Ito 4, Shigeru Watanabe 4, Masako Yokoyama 5, Kazuo Funatsu 5, Hitoshi Miyake 6, Hirokazu Yokoyama 7, Toshihiko Shimizu 1 and Mamoru Shibata 1 Abstract Objective The goal of this study was to determine the prevalence and clinical characteristics of headaches among socially active people working in the Tokyo metropolitan area. Methods We cross-sectionally surveyed 7,917 individuals. The survey assessed demographic characteristics, the prevalence and characteristics of headaches and physician attendance. Results The lifetime prevalence of migraines was 8.9%, while that of tension-type headaches was 14.7%. Women exhibited a higher prevalence of migraines than men (15% vs. 3.7%; p<0.001). The prevalence of migraines and tension-type headaches differed among occupations. Susceptibility to migraines and tensiontype headaches related to working overtime was observed. With respect to the influence of migraines on social activities, 22.4% of the migraineurs had been obliged to miss work due to headaches several times a year. As many as 59.4% of the sufferers had never consulted a physician about their headaches. Moreover, 24.6% of the migraineurs were not in touch with any physician at the time of the survey. The most common reason why they had stopped visiting their physician was that they had been told their headaches were not fatal. Conclusion Migraines adversely affect social activities. These data provide important information for understanding the features of migraines and tension-type headaches in socially active people working in the Tokyo metropolitan area. Key words: migraine, tension-type headache, prevalence, overtime work, doctor attendance (Intern Med 53: , 2014) () Introduction Headaches are the most common neurological symptom in humans, and it has been reported that nearly half of the world s adult population suffers from active headaches. Migraines and tension-type headaches are included as primary headaches in the second edition of the International Classification of Headache Disorders (ICHD-II) (1). Among primary headaches, migraines significantly impact the patient s quality of life (2, 3). It is estimated that nearly 10% of the general population suffers from this potentially disastrous cephalalgic disorder, which mostly affects those between 35 and 45 years of age. The high prevalence of migraines observed during the peak years of employment results in a substantial financial burden on society due to increased Department of Neurology, School of Medicine, Keio University, Japan, Otemachi Medical Center, Mizuho Health Insurance Society, Japan, Health Administration Center, Aoyama Gakuin University, Japan, Tokyo Health Administration Center, Nippon Life Insurance Company, Japan, Mitsukoshi Health and Welfare Foundation Mitsukoshi Clinic, Japan, Fujitsu Limited, Health Promotion Unit, Japan and Health Center, Keio University, Japan Received for publication September 3, 2013; Accepted for publication October 14, 2013 Correspondence to Dr. Toshihiko Shimizu, shimizu-toshi@umin.ac.jp 683
2 medical costs and lost productivity in the United States of America and European countries (4, 5). Therefore, a large number of epidemiological studies of migraines and their economic impact have been published in these countries (6-8). However, in Japan, only a few studies have evaluated the prevalence of primary headaches, such as migraines, in the general population, and fewer still have investigated the prevalence of headaches in the workplace (9, 10). In this study, we determined the prevalence and characteristics of headaches among subjects in the prime of life, defined as socially active individuals, working in the Tokyo metropolitan area. In addition, our study provides important information regarding physician attendance among migraine sufferers in Japan, where triptans have been available for almost ten years. Materials and Methods Between September 2007 and September 2008, we conducted a survey of the prevalence and characteristics of headaches at four institutions located in the Tokyo metropolitan area. These institutions comprised a university hospital, department store, insurance company and computer manufacturing company. A self-administered questionnaire including items assessing demographic characteristics (age, sex and occupation), the incidence of headaches, characteristics of headaches, the frequency of seeking medical attention due to headaches and the relationship between the frequency and severity of headaches and burdens on work within the past 12 months was distributed to all staff at these institutions (Table 1). Questionnaires with missing data for age, sex or occupation were eliminated from the analysis. We diagnosed the type of headache based on the answers provided in the questionnaire. The questionnaire included diagnostic criteria for migraine without aura, such as the frequency, duration and characteristics of headaches, as well as accompanying symptoms, including nausea or photophobia. A migraine was diagnosed if the headache fulfilled these criteria. However, the questionnaire did not include details about aura. Although the questionnaire included questions regarding visual symptoms, such as the occurrence of scintillating scotoma before the headache, it was difficult to diagnose whether the symptoms were truly indicative of focal cerebral dysfunction as defined by the ICHD-II (1). Therefore, in our study, both migraine without aura and migraine with aura were simply classified as migraines. Tension-type headaches were also diagnosed according to the ICHD-II diagnostic criteria. If the headache fulfilled the diagnostic criteria for infrequent episodic, frequent episodic or chronic tension-type headaches, the headache was diagnosed as tension-type headache. Since patients can receive more than one diagnosis in the ICHD-II, respondents with both migraines and tension-type headaches were are included in both the diagnostic group with migraines and the diagnostic group with tension-type headaches. Frequency and contingency tables were used to examine categorical data, which were evaluated with the χ 2 and McNemar tests. A multivariate logistic regression analysis was performed with the prevalence of migraines and tension-type headaches as the dependent variable and occupation, occupational position, sex, age and duration of overtime work as independent variables. Because there were sex differences in the prevalence of migraines and tension-type headaches, we evaluated the independent variables (occupation, occupational position and duration of overtime work) according to sex and thus created new independent variables. Another multivariate logistic regression analysis was performed using the new independent variables, with the prevalence of migraines and tension-type headaches as the dependent variable. The goodness of fit was evaluated according to the Hosmer and Lemeshow test and omnibus tests of model coefficients. Odds ratios (ORs) and their 95% confidence intervals (CIs) are presented. All statistical analyses were performed using the SPSS version 20.0 software package (SPSS Inc.). A value of p<0.01 was considered to be statistically significant. All questionnaire data were obtained after the respondents provided their informed consent, and the study was approved by the Keio University institutional review board (approval ID: ). Results Completed questionnaires were received from 7,917 individuals (4,160 men, 3,675 women, 112 missing sex data); a 77% response rate. Of the responders, 46% were women (Table 2). Lifetime prevalence of migraines and tension-type headaches Among the respondents, the lifetime prevalence of migraines was 8.9% (n=704), while that of tension-type headaches was 14.7% (n=1,167). In terms of sex, the prevalence of migraines was 3.7% (n=154) among 4,159 men and 15% (n=545) among 3,638 women (Table 2). The female/male ratio was 4.1. Women exhibited a higher prevalence of migraines than men (p<0.001, χ 2 test). The highest prevalence of migraines was among subjects between 35 and 39 years of age (19.3%; n=149) in women (n=773) and between those 25 and 29 years of age (7.0%; n=17) in men (n=244). The prevalence of tension-type headaches was 13.2% (n= 552) among men and 16.7% (n=606) among women (Table 2). Women also showed a higher prevalence of tensiontype headaches than men (p<0.001, χ 2 test). Association between the prevalence of headaches and occupation The OR of migraines for women in clerical, sales, system engineering, nursing and other occupations was 3.90 (95% CI= ), 4.64 (95% CI= ), (95% CI= ), 3.68 (95% CI= ) and 4.06 (95% CI= 684
3 Table 1. A Self-administered Questionnaire 685
4 Table 2. Lifetime Prevalence of Migraines and Tension-type Headaches by Sex and Age Group Sex Age Total Migraine Tension-type headache Sample Men (0%) 0 (0%) (1.0%) 11 (10.5%) (7%) 33 (13.5%) (4.7%) 78 (18.5%) (6.0%) 95 (17.4%) (5.6%) 130 (20.9%) (3.9%) 84 (18.1%) (2.1%) 65 (8.7%) (1.3%) 39 (5.8%) (1.5%) 17 (5.1%) Total 4, (3.7%) 552 (13.2%) Women 6 1 (16.7%) 0 (0%) (11.8%) 37 (16.8%) (13.4%) 79 (20.3%) (12.6%) 94 (18.0%) (19.3%) 135 (17.5%) (18.8%) 113 (20.1%) (18.3%) 78 (17.6%) (11.9%) 41 (12.5%) (7.4%) 22 (7.8%) (3.5%) 7 (6.2%) Total 3, (15.0%) 606 (16.7%) Unstated (4.2%) 9 (7.5%) Total 7, (8.9%) 1,167 (14.7%) Table 3. Association between the Prevalence of Migraines and Occupation Sex and Migraine (n = 693) Type of Odds ratio (95% CI) p Occupation Men: Clerical 1 (reference) Men: Sales 1.47 ( ) 0.22 Men: R & D 1.87 ( ) 0.08 Men: SEs 1.01 ( ) 0.97 Men: Physicians 0.44 ( ) 0.20 Men: Lab. Assistants 2.64 ( ) 0.29 Men: Others 0.88 ( ) 0.73 Women: Clerical 3.90 ( ) Women: Sales 4.64 ( ) Women: SEs ( ) Women: Physicians 2.97 ( ) 0.02 Women: Nurses 3.68 ( ) Women: Pharmacists 7.93 ( ) 0.02 Women: Lab. Assistants 2.74 ( ) 0.03 Women: Others 4.06 ( ) R & D: Research and Development SEs: System engineers Table 4. Association between the Prevalence of Tension-type Headaches and Occupation Sex and Tension-type headache (n = 1,138) Type of Odds ratio (95% CI) p Occupation Men: Clerical 4.06 ( ) Men: Sales 2.76 ( ) Men: R & D 2.17 ( ) 0.03 Men: SEs 4.00 ( ) Men: Physicians 9.22 ( ) Men: Lab. Assistants 1.53 ( ) 0.64 Men: Others 4.61 ( ) Women: Clerical 1.04 ( ) 0.87 Women: Sales 0.87 ( ) 0.64 Women: SEs 0.37 ( ) 0.11 Women: Physicians 1.36 ( ) 0.52 Women: Nurses 1.10 ( ) 0.75 Women: Pharmacists 0.51 ( ) 0.45 Women: Lab. Assistants 1.48 ( ) 0.42 Women: others 1 (reference) R & D: Research and Development SEs: System engineers ), respectively, compared with men employed as clerical personnel (Table 3). In terms of tension-type headaches, the OR for men employed as clerical personnel, sales personnel, system engineers, physicians and others was 4.06 (95% CI= ), 2.76 (95% CI= ), 4.00 (95% CI= ), 9.22 (95% CI= ) and 4.61 (95% CI= ), respectively, compared with women in the other occupations category (Table 4). Duration of overtime work We analyzed the association between the incidence of headaches and the duration of overtime work. As shown in Table 5, the OR of migraines for men worked <45 h/month of overtime and those who worked 45 h/month of overtime was 0.34 (95% CI= ) and 0.35 (95% CI= ), respectively, compared with women who worked 45 h/ 686
5 Table 5. Association between the Incidence of Headaches and the Duration of Overtime Work Sex and Migraine (n = 693) Tension-type headache (n = 1,138) the duration of Odds ratio (95% CI) p Odds ratio (95% CI) p overtime work Men: <45 h/month 0.34 ( ) ( ) Men: 45 h/month 0.35 ( ) ( ) Women: <45 h/month 1.35 ( ) ( ) 0.28 Women: 45 h/month 1 (reference) 1 (reference) Men: <45 h/month 1 (reference) 1 (reference) Men: 45 h/month 1.03 ( ) ( ) 0.87 Women: <45 h/month 3.92 ( ) ( ) Women: 45 h/month 2.90 ( ) ( ) month. Among women, the OR of migraines for those who worked <45 h/month and those who worked 45 h/month was 3.92 (95% CI= ) and 2.90 (95% CI= ), respectively, compared with men who worked <45 h/month. In terms of tension-type headaches, the OR for men who worked <45 h/month and those who worked 45 h/month was 2.90 (95% CI= ) and 2.79 (95% CI= ), respectively, compared with women who worked 45 h/ month. Among women, the OR of tension-type headaches for those who worked <45 h/month and those who worked 45 h/month was 0.25 (95% CI= ) and 0.34 (95% CI= ), respectively, compared with men who worked <45 h/month. Influence on social activities The influence of migraine on social activities was remarkable, as witnessed by the fact that 25.1% of the migraineurs (n=704) had been obliged to miss work due to headaches several times during the course of a single year. In fact, 2.7% of the 704 migraineurs were unable to work once a month. In comparison, tension-type headache sufferers (n= 1,167) were less frequently affected in terms of restrictions on their social activities; 89.9% reported no impact of headaches on their work. Therefore, our results indicate that the effects of migraines on social activities are greater than those of tension-type headaches (p<0.001, χ 2 test). Physician attendance and medication use Among the migraineurs (n=704), only 1.3% regularly visited their physicians, and 59.4% had never consulted with a physician about their headaches. A total of 24.6% were not in touch with any physician at the time of the survey and 12.5% visited their physician on an as-needed basis. Among the tension-type headache sufferers (n= 1,167), 79.7% had never visited a physician about their headaches, 12.5% had visited a physician only in the past, 6.2% visited a physician on an as-needed basis and 0.5% reported visiting a physician regularly. Although both the migraine and tension-type headache sufferers exhibited a low rate of physician attendance, the percentage of respondents visiting a physician was significantly higher among the migraineurs than among the tension-type headache sufferers (p<0.001, χ 2 test). The most common reason why respondents stopped visiting their physician (n=173 in migraineurs who had visited a physician; n=146 in tension-type headache sufferers who had visited a physician) was that they had been told that their headaches were not fatal (45.1% of migraineurs and 45.9% of tension-type headache sufferers). The rate of this response was significantly higher than that of the other reasons (p<0.0001, McNemar test). The second most common reason was that the respondents had been unable to obtain adequate advice about their headaches from their physician (20.2% of migraineurs and 10.3% of tension-type headache sufferers). Other reasons included that there was no time to see a physician (14.5% of migraineurs and 8.9% of tension-type headache sufferers) and that no headache medications were given on past visits to a physician (2.9% of migraineurs and 0.7% of tension-type headache suffers). In regard to how the headache sufferers dealt with their headaches, the respondent reported that they tended to use drugs obtained from pharmacies (60.8% of the 704 migraineurs and 48.1% of the 1,167 tension-type headache sufferers, both proportions were significantly higher than that for other headache types; p<0.0001, McNemar test). The second most common measure for dealing with headaches was physical therapy (46.0% of migraineurs and 32.6% of tension-type headache sufferers). Only 23.2% of the migraineurs and 15.9% of the tension-type headache sufferers reported using drugs prescribed at medical institutions. Doing nothing in particular to relieve their headaches was reported by 2.4% of the migraineurs and 15.1% of the tension-type headache sufferers. Discussion Our study revealed the prevalence of migraines and tension-type headaches among workers in the metropolitan area around Tokyo. A previous nationwide survey in Japan demonstrated that the overall prevalence of migraines was 8.4%, while that of tension-type headaches was 22.4% (9). Another population-based survey in Japan revealed that the one-year prevalence of migraines and tension-type headaches was 6.0% and 21.7%, respectively (10). Our data are consistent with previously reported incidences of migraines 687
6 and tension-type headaches; therefore, it is inferred that our questionnaire is appropriate for screening primary headaches, although it did not completely eliminate the detection of secondary headaches. Since the lifetime prevalence of headaches is known to exhibit a cumulative trend, the incidence of headaches is expected to reach a saturated level in midlife and maintain a steady-state level thereafter. However, our data indicated that the lifetime prevalence of migraines and tension-type headaches tended to be lower at older ages. Similar observations have been reported in other surveys (11-14). According to these studies, this discrepancy can be explained by recall bias, which refers to the tendency to report the most recent experience with headaches, as well as cohort effects and mortality bias. Therefore, these factors may have also affected the lifetime prevalence of migraines and tension-type headaches in this study. The present study also examined the association between the prevalence of headaches and occupation. Although many clinicians have the impression that there is an association between the prevalence of headaches and occupation, there have thus far been no published epidemiological data showing such an association. Therefore, in this study, we demonstrated differences in the prevalence of headaches among various types of jobs for the first time. Since several epidemiological studies have raised the possibility that long work hours constitute a risk factor of cerebro- and cardiovascular diseases, we evaluated the association between the prevalence of migraines or tension-type headaches and overtime work (15, 16). In Japan, employers make efforts to reduce the number of overtime work hours in order to improve accumulated fatigue due to excessive work. As a consequence, the Ministry of Health, Labour and Welfare of Japan revised the Labour Standards Act, and Japanese employers are now required to limit the number of overtime hours an employee can work to 45 hours per month (Ministry of Health, Labour and Welfare of Japan. Revised Labour Standards Act. english/policy/affairs/dl/07.pdf., 5 October 2013, date last accessed). Therefore, we used 45 hours per month as a cutoff value to assess the impact of overtime. However, our data did not show a robust increase in the prevalence of headaches in the subjects who worked more than 45 hours per month of overtime work. These findings suggest that it is important to set the cut-off value to less than 45 hours per month of overtime in order to reduce the impact of headaches induced by overtime work. The present study found that approximately 60% of migraine patients had never consulted a physician, despite experiencing a remarkable influence of headaches on their social life. Migraines are known to cause severe disability in their social activities. However, only a fraction of headache patients seek medical assistance from a doctor (17). Some studies have indicated the possibility that the low rate of physician attendance results in the reliance of a large number of migraineurs on over-the-counter medications to treat their headaches (18, 19). In fact, our data also indicated that approximately 60% of migraineurs use over-the-counter analgesics (20, 21). This is likely to put migraine sufferers at a greater risk of developing medication-overuse headaches. Several studies have attempted to address this issue by exploring reasons why migraine and tension-type headache patients do not seek medical attention (22, 23). In addition to these studies, Kotani et al. conducted a survey of this issue in Japanese migraine and tension-type headache patients (24). According to these reports, reasons for not seeking medical attention include an insufficient severity of headaches and/or the amenability of the headaches to overthe-counter medications. An important finding of this study is the identification of reasons why migraine and tensiontype headache patients in Japan do not consult physicians. Although the response that the subjects did not obtain adequate advice about their headaches from their physician was a similar reason to that observed in the results of a Canadian Population Survey, the answers that the headaches were not fatal and there was no time to see a physician were not included in the results of that survey. These findings provide important clues to preventing Japanese headache patients from not consulting a physician. However, our population-based study has potential limitations related to recall and selection bias. Recall bias may be present because the recall of events occurring almost a decade in the past is likely to be imperfect. In addition, selection bias may have affected our results because we included only four institutions in this study. Despite these caveats, our data provide intriguing information in terms of the prevalence of primary headaches among socially active people working in the Tokyo metropolitan area. Furthermore, our study highlights the potential importance of providing lectures by headache specialists for office workers who suffer from headaches. Author s disclosure of potential Conflicts of Interest (COI). Nobuhiko Ito: Employment, Nippon Life Insurance. Shigeru Watanabe: Employment, Nippon Life Insurance. Hitoshi Miyake: Employment, Fujitsu. Acknowledgement The authors express our gratitude to Professor Kazuyuki Omae (Department of Preventive Medicine and Public Health, School of Medicine, Keio University) for his insightful comments on the statistical analysis in this article. This research received no specific grants from any funding agency in the public, commercial or not-for-profit sectors. References 1. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia 24 (Suppl. 1): 9-160, Freitag FG. The cycle of migraine: patients quality of life during and between migraine attacks. Clin Ther 29: , Turner-Bowker DM, Bayliss MS, Ware JE Jr, Kosinski M. Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditions. Qual Life Res 12: ,
7 4. Hazard E, Munakata J, Bigal ME, Rupnow MF, Lipton RB. The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis. Value Health 12: 55-64, Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27: , Lampl C, Buzath A, Baumhackl U, Klingler D. One-year prevalence of migraine in Austria: a nation-wide survey. Cephalalgia 23: , Linde M, Dahlof C. Attitudes and burden of disease among selfconsidered migraineurs--a nation-wide population-based survey in Sweden. Cephalalgia 24: , Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41: , Sakai F, Igarashi H. Prevalence of migraine in Japan: a nationwide survey. Cephalalgia 17: 15-22, Takeshima T, Ishizaki K, Fukuhara Y, et al. Population-based door-to-door survey of migraine in Japan: the Daisen study. Headache 44: 8-19, Carson AP, Rose KM, Sanford CP, et al. Lifetime prevalence of migraine and other headaches lasting 4 or more hours: the Atherosclerosis Risk in Communities (ARIC) study. Headache 44: 20-28, O Brien B, Goeree R, Streiner D. Prevalence of migraine headache in Canada: a population-based survey. Int J Epidemiol 23: , Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population--a prevalence study. J Clin Epidemiol 44: , Svensson DA, Ekbom K, Larsson B, Waldenlind E. Lifetime prevalence and characteristics of recurrent primary headaches in a population-based sample of Swedish twins. Headache 42: , Spurgeon A, Harrington JM, Cooper CL. Health and safety problems associated with long working hours: a review of the current position. Occup Environ Med 54: , van der Hulst M. Long workhours and health. Scand J Work Environ Health 29: , Tepper SJ, Dahlof CG, Dowson A, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study. Headache 44: , Berry PA. Migraine disorder: workplace implications and solutions. Aaohn J 55: 51-56, Pop PH, Gierveld CM, Karis HA, Tiedink HG. Epidemiological aspects of headache in a workplace setting and the impact on the economic loss. Eur J Neurol 9: , Bigal ME, Lipton RB. Overuse of acute migraine medications and migraine chronification. Curr Pain Headache Rep 13: , Smith TR, Stoneman J. Medication overuse headache from antimigraine therapy: clinical features, pathogenesis and management. Drugs 64: , Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on lifestyle, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci 20: , Oliveira DR, Leite AA, Rocha-Filho PA. Which patients with headache do not seek medical attention? Headache 51: , Kotani K, Shimomura T, Ikawa S, Sakane N, Ishimaru Y, Adachi S. Japanese with headache: suffering in silence. Headache 44: , The Japanese Society of Internal Medicine 689
The prevalence and characteristics of migraine among the Belgian working population
Acta neurol. belg., 2007, 107, 84-90 The prevalence and characteristics of migraine among the Belgian working population Guido MOENS 1,2, Kristien JOHANNIK 1, Chris VERBEEK 1,2 and Simon BULTERYS 1,2 1
More informationMigraine much more than just a headache
Migraine much more than just a headache Session hosted by Teva UK Limited PUU4 11:15 12:15 UK/NHSS/18/0021b Date of Preparation: August 2018 The views expressed in this presentation are those of the speaker
More informationMigraine Diagnosis and Treatment: Results From the American Migraine Study II
Migraine Diagnosis and Treatment: Results From the American Migraine Study II Richard B. Lipton, MD; Seymour Diamond, MD; Michael Reed, PhD; Merle L. Diamond, MD; Walter F. Stewart, MPH, PhD Objective.
More informationPrevalence and Impact of Migraine and Tension-Type Headache in Korea
ORIGINAL ARTICLE J Clin Neurol 212;8:24-211 Print ISSN 1738-6586 / On-line ISSN 25-513 http://dx.doi.org/1.3988/jcn.212.8.3.24 Open Access Prevalence and Impact of Migraine and Tension-Type Headache in
More informationPrevalence of primary headaches in Germany: results of the German Headache Consortium Study
J Headache Pain (2012) 13:215 223 DOI 10.1007/s10194-012-0425-x ORIGINAL Prevalence of primary headaches in Germany: results of the German Headache Consortium Study M-S Yoon Z. Katsarava M. Obermann G.
More informationThe Economic and Social Impact of Migraine Key Words
Paper Eur Neurol 1994;34(suppl 2):12-17 W.F. Walter F. Stewart a R.B. Richard B. Lipton b a Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Md., b Departments of Neurology,
More informationUNDERSTANDING CHRONIC MIGRAINE. Learn about diagnosis, management, and treatment options for this headache condition
UNDERSTANDING CHRONIC MIGRAINE Learn about diagnosis, management, and treatment options for this headache condition 1 What We re Going to Cover Today The symptoms and phases of migraine Differences between
More informationMigraine Disability Awareness Campaign in Asia: Migraine Assessment for Prophylaxis
Headache 2008 the Authors Journal compilation 2008 American Headache Society ISSN 0017-8748 doi: 10.1111/j.1526-4610.2008.01088.x Published by Wiley Periodicals, Inc. Research Submission Migraine Disability
More informationMigraine is a very common medical disorder
MENSTRUALLY RELATED MIGRAINE: IMPLICATIONS FOR EMPLOYERS AND MANAGED CARE * Richard B. Lipton, MD ABSTRACT Migraine is a common disorder, affecting approximately 28 million men and women in the United
More informationCover Page. Author: Smelt, Antonette Title: Treatment of migraine : from clinical trial to general practice Issue Date:
Cover Page The handle http://hdl.handle.net/1887/25761 holds various files of this Leiden University dissertation Author: Smelt, Antonette Title: Treatment of migraine : from clinical trial to general
More informationMEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache
MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache Measure Description Percentage of patients age 18 years old and older diagnosed with migraine headache whose migraine frequency is 4 migraine
More informationRISK FACTORS AND PROGNOSIS OF CHRONIC MIGRAINE
RISK FACTORS AND PROGNOSIS OF CHRONIC MIGRAINE Gretchen E. Tietjen, MD University of Toledo Toledo, Ohio Learning objectives At the conclusion of this presentation, participants should be able to: 1. Understand
More informationEpidemiology of migraine
J Headache Pain (2003) 4:S18 S22 Springer-Verlag 2003 GLOBAL BURDEN Gian Camillo Manzoni Paola Torelli Epidemiology of migraine G.C. Manzoni ( ) P. Torelli Headache Centre, Institute of Neurology, University
More informationMigraine headache is one of the
CLINICAL DECISION MAKING Simplifying the Diagnosis of Migraine Headache Vincent T. Martin, MD ABSTRACT Migraine headache is a very common disease encountered by primary care physicians. Its prevalence
More informationTension Type Headache and Percieved Stress Level: A Correlational Study
The International Journal of Indian Psychology ISSN 2348-5396 (e) ISSN: 2349-3429 (p) Volume 4, Issue 1, No. 76, DIP: DIP: 18.01.019/20160476 ISBN: 978-93-86162-13-7 http://www.ijip.in October, 2016 Tension
More informationTreatment of migraine and tension-type headache in Croatia
J Headache Pain (2010) 11:227 234 DOI 10.1007/s10194-010-0200-9 ORIGINAL Treatment of migraine and tension-type headache in Croatia Vlasta Vuković Davor Plavec Arijana Lovrenčić Huzjan Mislav Budišić Vida
More informationControversy One: Headache and Disability. Robert Shapiro, MD, PhD University of Vermont
Controversy One: Headache and Disability Robert Shapiro, MD, PhD University of Vermont Southern Headache Society Orlando, FL, Sept 21, 2013 Disclosures Consulting within the past 12 months: Transcept Pharmaceuticals
More informationA one-year prospective costing study of botulinum toxin type A treatment of chronic tension headache
J Headache Pain (2004) 5:192 196 DOI 10.1007/s10194-004-0100-3 ORIGINAL Fabio Palazzo Francesco S. Mennini Laura Fioravanti Laura Piasini Gabriella Coloprisco Paolo Martelletti A one-year prospective costing
More informationClinical Study Headache Associated with Myasthenia Gravis: The Impact of Mild Ocular Symptoms
SAGE-Hindawi Access to Research Autoimmune Diseases Volume 2011, Article ID 840364, 4 pages doi:10.4061/2011/840364 Clinical Study Headache Associated with Myasthenia Gravis: The Impact of Mild Ocular
More informationEpidemiology and Burden of Headache
D A N I S H H E A D A C H E C E N T E R Epidemiology and Burden of Headache EHF Headache Summer school in Belgrade Rigmor Hoejland Jensen, Professor, Dr.Med.Sci., Danish Headache Center, Department of
More informationSelf-reported headache among the employees of a Swiss university hospital: prevalence, disability, current treatment, and economic impact
Sokolovic et al. The Journal of Headache and Pain 2013, 14:29 RESEARCH ARTICLE Open Access Self-reported headache among the employees of a Swiss university hospital: prevalence, disability, current treatment,
More informationChronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary
Chronic Migraine in Primary Care December 11 th, 2017 Werner J. Becker University of Calgary Disclosures Faculty: Werner J. Becker Relationships with commercial interests: Grants/Research Support: Clinical
More informationMigraine attacks in the pharmacy: a survey in Piedmont, Italy
DOI 10.1007/s10072-014-1733-5 FICEF SYMPOSIUM - HEADACHE IN THE FRONT LINE: FROM PHARMACIST TO GENERAL PRACTITIONER Migraine attacks in the pharmacy: a survey in Piedmont, Italy P. Brusa G. Allais G. Bussone
More informationPREVALENCE BY HEADACHE TYPE
CLINICAL CLUES AND CLINICAL RULES: PRIMARY VS SECONDARY HEADACHE * Based on a presentation by David W. Dodick, MD ABSTRACT Headache is a common condition, accounting for many specialist office visits annually.
More informationThe validity of questionnaire-based diagnoses: the third Nord-Trøndelag Health Study
J Headache Pain (2010) 11:67 73 DOI 10.1007/s10194-009-0174-7 ORIGINAL The validity of questionnaire-based diagnoses: the third Nord-Trøndelag Health Study 2006 2008 Knut Hagen John-Anker Zwart Anne Hege
More informationTitle: Diagnosing migraine in research and clinical settings: The Validation of the Structured Migraine Interview (SMI)
Author's response to reviews Title: Diagnosing migraine in research and clinical settings: The Validation of the Structured Migraine Interview (SMI) Authors: Zainab Samaan (z.samaan@iop.kcl.ac.uk) E Anne
More informationInteractions between migraine and tension-type headache and alcohol drinking, alcohol flushing, and hangover in Japanese
J Headache Pain (2012) 13:137 145 DOI 10.1007/s10194-011-0413-6 ORIGINAL Interactions between migraine and tension-type and alcohol drinking, alcohol flushing, and hangover in Japanese Masako Yokoyama
More informationPrevalence of headache in an elderly population: attack frequency, disability, and use of medication
J Neurol Neurosurg Psychiatry 2001;70:377 381 377 Department of Neurological Sciences, La Sapienza University, Via dell Amba Aradam 21, 00184 Rome Rome, Italy M Prencipe A R Casini C Ferretti M Santini
More informationMigraine Types and Triggering Factors in Children
original ARTICLE Migraine Types and Triggering Factors in Children How to Cite this Article: Nejad Biglari H, Karimzadeh P, Mohammadi Kord-kheyli M, Hashemi SM. Migraine Types and Triggering Factors in
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
CGRP Page 1 of 8 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: CGRP (calcitonin gene-related peptide) Prime Therapeutics will review Prior Authorization requests
More informationMigraine strikes study: factors in patients decision to treat early
J Headache Pain (2009) 10:93 99 DOI 10.1007/s10194-008-0091-1 ORIGINAL Migraine strikes study: factors in patients decision to treat early Wendy Golden Æ Judith K. Evans Æ Henry Hu Received: 17 October
More informationValue of postmarketing surveillance studies in achieving a complete picture of antimigraine agents: using almotriptan as an example
J Headache Pain (2006) 7:27 33 DOI 10.1007/s10194-006-0266-6 ORIGINAL Julio Pascual Hans-Christoph Diener Hélène Massiou Value of postmarketing surveillance studies in achieving a complete picture of antimigraine
More informationSocio-economic costs of migraine
J Headache Pain (2001) 2:S15 S19 Springer-Verlag 2001 MIGRAINE AND DISABILITY Rosanna Cerbo Marina Pesare Cinzia Aurilia Valeria Rondelli Piero Barbanti Socio-economic costs of migraine R. Cerbo ( ) M.
More informationA new questionnaire for assessment of adverse events associated with triptans: methods of assessment influence the results. Preliminary results
J Headache Pain (2004) 5:S112 S116 DOI 10.1007/s10194-004-0123-4 Michele Feleppa Fred D. Sheftell Luciana Ciannella Amedeo D Alessio Giancarlo Apice Nino N. Capobianco Donato M.T. Saracino Walter Di Iorio
More informationHeadache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, II. Management of Refractory Headaches
Headache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, 2016 II. Management of Refractory Headaches Case presentation 1: A case of intractable daily-persistent headache Keio University School
More informationMEASURE #9: MIGRAINE OR CERVICOGENIC HEADACHE RELATED DISABILITY FUNCTIONAL STATUS Headache Quality Improvement Only
MEASURE #9: MIGRAINE OR CERVICOGENIC HEADACHE RELATED DISABILITY FUNCTIONAL STATUS Headache Quality Improvement Only Measure Description Percentage of patients age 6 years old and older who have a diagnosis
More informationTension-type headache Comorbidities EHF-summerschool Belgrade May 2012
Tension-type headache Comorbidities EHF-summerschool Belgrade May 2012 Conflicts of Interest: Lectures for Pfizer, Berlin-Chemie, Allergan, Merck Member of advisory boards in: ATI, Medotech, Neurocore,
More informationMIGRAINE ASSOCIATION OF IRELAND
MIGRAINE ASSOCIATION OF IRELAND HEADACHE IN MEN: THE FACTS This leaflet was composed by Paolo Rossi M.D., Ph.D. of the European Headache Alliance to mark European Migraine Day of Action 2014. Why a leaflet
More informationZolmitriptan is effective and well tolerated in Japanese patients with migraine: a dose response study
is effective and well tolerated in Japanese patients with migraine: a dose response study F Sakai 1, M Iwata 2, K Tashiro 3, Y Itoyama 4, S Tsuji 5, Y Fukuuchi 6, G Sobue 7, K Nakashima 8 & M Morimatsu
More informationThe prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients
Blackwell Publishing LtdOxford, UKCHACephalalgia0333-1024Blackwell Science, 20062006261012091213Original ArticleThe prevalence of premonitory symptoms in migrainegg Schoonman et al. The prevalence of premonitory
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
CGRP Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: CGRP (calcitonin gene-related peptide) Prime Therapeutics will review Prior Authorization requests
More informationLasmiditan (200 mg and 100 mg) Compared to Placebo for Acute Treatment of Migraine
(200 mg and 100 mg) Compared to for Acute Treatment of Migraine Bernice Kuca, M.S. 1 ; Linda A. Wietecha, B.S.N., M.S. 2 ; Paul H. Berg, M.S. 2 ; Sheena K. Aurora, M.D. 2 1 CoLucid Pharmaceuticals, Inc.,
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Frequency Domain Analysis of Heart Rate Variability in Tension Type Headache: A Case Control
More informationDoes analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse
DOI 10.1186/s40064-015-1386-8 RESEARCH Open Access Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse Fayyaz Ahmed *, Hassan
More informationEpidemiological studies are the basis for
XASIM Feb p45-50 4/5/01 9:27 AM Page 45 THE EPIDEMIOLOGY OF MIGRAINE AND HEADACHE DISORDERS* Hartmut Göbel, MD, PhD Kiel Pain Clinic, Germany ABSTRACT The development of the diagnostic and classification
More informationLifting The Burden. WHO s Global Campaign to Reduce the Burden of Headache Worldwide. TJ Steiner
Lifting The Burden WHO s Global Campaign to Reduce the Burden of Headache Worldwide TJ Steiner Division of Neuroscience and Mental Health Imperial College London 04/03/09 TJ Steiner 1 The argument (as
More informationClassification of headaches
Classification of headaches Jasna Zidverc Trajković Headache center Headache in adults: 1-year prevalence 13.4 Kryst 35.9 Miranda 28.7 Jaillard 87.3 O Brien 63.1 Wiehe 37.3 Lavados 59.7 Schwartz 76.0 Boardman
More informationPredicting failure to follow-up screened high blood pressure in Japan: a cohort study
Journal of Public Health Vol. 37, No. 3, pp. 498 505 doi:10.1093/pubmed/fdu056 Advance Access Publication August 7, 2014 Predicting failure to follow-up screened high blood pressure in Japan: a cohort
More informationStatistical analysis of longitudinal studies: how to evaluate changes in risk factor and outcome?
Disclosure Statistical analysis of longitudinal studies: how to evaluate changes in risk factor and outcome? This presentation expresses my views, shaped by discussions with co-authors, colleagues, conference
More informationTABLE 1. Current Diagnostic Criteria for Migraine Without Aura 2 A. At least 5 attacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours
ANSWERS CONCISE TO FREQUENTLY REVIEW ASKED QUESTIONS FOR CLINICIANS ABOUT MIGRAINE Answers to Frequently Asked Questions About Migraine IVAN GARZA, MD, AND JERRY W. SWANSON, MD Migraine is a common primary
More informationPhysiotherapy for tension-type headache: a controlled study
Blackwell Science, LtdOxford, UKCHACephalalgia1468-2982Blackwell Science, 232412936Original ArticlePhysiotherapy for tension-type headachep Torelli et al. Physiotherapy for tension-type headache: a controlled
More informationA case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:
Chronic Daily Headache Bassel F. Shneker, MD, MBA Associate Professor Vice Chair, OSU Neurology The Ohio State University Wexner Medical Center Financial Disclosures None related to the presentation Grants
More informationThe global burden of migraine
J Headache Pain (2003) 4:S3 S11 Springer-Verlag 2003 GLOBAL BURDEN Richard B. Lipton Marcelo E. Bigal Ann I. Scher Walter F. Stewart The global burden of migraine R.B. Lipton ( ) M.E. Bigal Department
More informationPrevalence of new daily persistent headache in the general population. The Akershus study of chronic headachecha_
doi:10.1111/j.1468-2982.2009.01842.x Prevalence of new daily persistent headache in the general population. The Akershus study of chronic headachecha_1842 1149..1155 RB Grande 1,2, K Aaseth 1,3, C Lundqvist
More informationMigraine and hormonal contraceptives
Migraine and hormonal contraceptives Department of Community Medicine, Systems Epidemiology University of Tromsø, November 2017 Nora Stensland Bugge Medical research student Presentation outline What is
More informationLearning objectives 6/20/2018
Cognitive impairment of patients with chronic migraine, in a neuropsychological assessment, does not depend on the use of topiramate or comorbidities Ferreira KS, MD, PhD Professor, Neurology Clinic, Medicine
More informationIs Yoga an Effective Treatment for Reducing the Frequency of Episodic Migraine?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2018 Is Yoga an Effective Treatment for Reducing
More informationPrevalence of Migraine Headache in Canada: A Population-Based Survey
International Journal of Epidemiology O International Epidemlologlcal Association 994 Vol. 23, 5 Printed In Great Britain Prevalence of Migraine Headache in Canada: A PopulationBased Survey BERNIE O'BRIEN,*"
More informationTo Study Etiological & Demographic Profile of Headache in Tertiary Neurocare Centre Of Mp
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 2 Ver. 14 February. (2018), PP 17-22 www.iosrjournals.org To Study Etiological & Demographic
More informationHigh dietary caffeine consumption is associated with a modest increase in headache prevalence: results from the Head-HUNT Study
J Headache Pain (2009) 10:153 159 DOI 10.1007/s10194-009-0114-6 ORIGINAL High dietary caffeine consumption is associated with a modest increase in headache prevalence: results from the Head-HUNT Study
More informationInpatient Treatment of Status Migraine With Dihydroergotamine in Children and Adolescents
Headache 2008 the Authors Journal compilation 2008 American Headache Society ISSN 0017-8748 doi: 10.1111/j.1526-4610.2008.01293.x Published by Wiley Periodicals, Inc. Brief Communication Inpatient Treatment
More informationResearch Article Reliability and Validity of the Migraine Disability Assessment Scale among Migraine and Tension Type Headache in Iranian Patients
BioMed Research International, Article ID 978064, 7 pages http://dx.doi.org/10.1155/2014/978064 Research Article Reliability and Validity of the Migraine Disability Assessment Scale among Migraine and
More informationDownloaded from journal.gums.ac.ir at 21:46 IRDT on Wednesday July 4th 2018
- *** -** -* * ** *** / : / :. :... : : ( ).. SPSS9. ( ) %. % % % :.. :. / / / :. %.( ) ( ).( ) % /.( ) ( / ).( ) % %.( ).( ).( ) 51 - : Ghayeghranamirreza@yahoo.com - - ( International headache Society
More informationIs the Migraid device an asset in the non-pharmacologic treatment of migraine?
Acta neurol. belg., 2007, 107, 40-46 Is the Migraid device an asset in the non-pharmacologic treatment of migraine? Herman PIETERSE 1,3, Joop A. M. KUSTER 2 and Luc M. VAN BORTEL 1 1 Heymans Institute
More informationUCNS Course A Review of ICHD-3b
UCNS Course A Review of ICHD-3b Andrew D. Hershey, M.D., Ph.D., FAHS Endowed Chair and Director of Neurology Director, Cincinnati Children s Headache Center Professor of Neurology and Pediatrics University
More informationMENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division
MENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division The costs of poor mental health Estimates of Direct and Indirect Costs of Mental Illness 1 All
More informationDoes repeated subcutaneous administration of sumatriptan produce an unfavorable evolution in cluster headache?
J Headache Pain (2004) 5:110 114 DOI 10.1007/s10194-004-0078-5 ORIGINAL Virginie Dousset Virginie Chrysostome Bruno Ruiz S. Irachabal Magalie Lafittau Françoise Radat Bruno Brochet Patrick Henry Does repeated
More informationMigraine affects about 1 of. Epidemiology of Migraine ...SYMPOSIUM PROCEEDINGS... Based on a presentation by Walter F.
...SYMPOSIUM PROCEEDINGS... Epidemiology of Migraine Based on a presentation by Walter F. Stewart, PhD, MPH Presentation Summary About one of every nine individuals in the United States suffers from migraine.
More informationHow accurately does the Brief Job Stress Questionnaire identify workers with or without potential psychological distress?
J Occup Health 2017; 59: 356-360 Brief Report How accurately does the Brief Job Stress Questionnaire identify workers with or without potential psychological distress? Akizumi Tsutsumi 1, Akiomi Inoue
More informationDefining the Differences Between Episodic Migraine and Chronic Migraine
Curr Pain Headache Rep (2012) 16:86 92 DOI 10.1007/s11916-011-0233-z CHRONIC DAILY HEADACHE (SJ WANG, SECTION EDITOR) Defining the Differences Between Episodic Migraine and Chronic Migraine Zaza Katsarava
More informationStudy No.:MPX Title: Rationale: Phase: IIB Study Period: Study Design: Centres: Indication: Treatment: Objectives:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationTemplate 1 for summarising studies addressing prognostic questions
Template 1 for summarising studies addressing prognostic questions Instructions to fill the table: When no element can be added under one or more heading, include the mention: O Not applicable when an
More informationThe Self Care: Be Your Best Report A global study on common health conditions and how people practice self care
The Self Care: Be Your Best Report 2018 A global study on common health conditions and how people practice self care Foreword Most of us have woken up recently with some type of pain, a blocked or runny
More informationHarold G. Wolff Lecture Award Winner
Headache 2008 the Authors Journal compilation 2008 American Headache Society ISSN 0017-8748 doi: 10.1111/j.1526-4610.2008.01217.x Published by Wiley Periodicals, Inc. Harold G. Wolff Lecture Award Winner
More informationSpecific Objectives A. Topics to be lectured and discussed at the plenary sessions
Specific Objectives A. Topics to be lectured and discussed at the plenary sessions 0. Introduction: Good morning ICHD-III! Let s start at the very beginning. When you read you begin with A-B-C, so when
More informationAdvances in the Treatment of Migraine
Advances in the Treatment of Migraine C. Philip O Carroll, M.D. Director Neurobehavioral Medicine Hoag Neurosciences Institute Guyuron B Headache, 2015;55:1464-1473 I m sorry your head hurts, sweetie.is
More informationHealth-care utilization for primary headache disorders in China: a population-based door-to-door survey
Liu et al. The Journal of Headache and Pain 2013, 14:47 RESEARCH ARTICLE Health-care utilization for primary headache disorders in China: a population-based door-to-door survey Open Access Ruozhuo Liu
More informationEconomic and social impact of migraine
Q J Med 1996; 89:77 84 Economic and social impact of migraine C.E. CLARKE, L. MacMILLAN1, S. SONDHI1 and N.E.J. WELLS1 From the Department of Neurology, Hull Royal Infirmary, Hull, and 1Glaxo Pharmaceuticals
More informationTreatment Of Medication. Overuse Headache
7 November 2012 BASH GPwSI Meeting Lecture title... Treatment Of Medication Dr... Overuse Headache Dr Marcus Lewis Dr... The National Migraine Centre International Headache Society Diagnostic criteria
More informationOveruse of barbiturate and opioid containing medications for primary headache disorders Description
Measure Title Overuse of barbiturate and opioid containing medications for primary headache disorders Description Percentage of s age 12 years and older with a diagnosis of primary headache who were prescribed
More informationA Case Study of Policy and Practice in Occupational Health. and Safety in South Australia. Grant Dewar
A Case Study of Policy and Practice in Occupational Health and Safety in South Australia Grant Dewar A dissertation submitted in partial fulfilment of the requirements for the degree of Master of Education
More informationMental Health in Workplaces in Taipei
26 Taiwanese Journal of Psychiatry (Taipei) Vol. 25 No. 1 2011 Original Article Mental Health in Workplaces in Taipei Mei-Ju Chen, M.D. MPH 1,2, Tony Szu-Hsien Lee, Ph.D. 3, Huey-Mei Jeng, Ph.D. 3, Wen-Hsiang
More informationAuthor's response to reviews
Author's response to reviews Title: Effect of a multidisciplinary stress treatment programme on the return to work rate for persons with work-related stress. A non-randomized controlled study from a stress
More informationeappendix S1. Studies and participants
eappendix S1. Studies and participants Eligible population from 11 cohort studies N = 96,211 Excluded: Missing data on exposure or outcome N = 6047 Analytic sample for study of minimally adjusted ERI-
More informationChapter 11: SF-36 Health Status Questionnaire: Health Risk Behaviours, Specific Conditions and Health Service Utilisation
Chapter 11: SF-36 Status Questionnaire: Risk Behaviours, Specific Conditions and Service Utilisation Key points Smoking status had some impact on self-reported health, particularly amongst non- Mäori,
More informationSurvey on Health Promotion and Working Women 2018 (Summary Report)
March 1, 2018 Survey on Health Promotion and Working Women 2018 (Summary Report) High health literacy was associated with high work performance The role of schools and companies was highlighted as sources
More informationSingle Use of Sumatriptan: A Patient Interview Study
Single Use of Sumatriptan: A Patient Interview Study H. Rahimtoola, PharmD; H. Buurma, PharmD; C.C. Tijssen, PharmD; H.G. Leufkens, PhD; A.C.G. Egberts, PhD Objective. To investigate the possible reasons
More informationChronic Migraine: Epidemiology and Disease Burden
Curr Pain Headache Rep (2011) 15:70 78 DOI 10.1007/s11916-010-0157-z Chronic Migraine: Epidemiology and Disease Burden Aubrey N. Manack & Dawn C. Buse & Richard B. Lipton Published online: 10 November
More information8-May-2018 ICER OPEN COMMENT PERIOD ON CGRP INHIBITORS FOR MIGRAINE. Submitted electronically to:
8-May-2018 ICER OPEN COMMENT PERIOD ON CGRP INHIBITORS FOR MIGRAINE Submitted electronically to: publiccomments@icer-review.org Steven D. Pearson, MD, President Institute for Clinical and Economic Review
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationRecognition and treatment of medication overuse headache
Recognition and treatment of medication overuse headache Marcus Lewis MA, MRCGP, DRCOG, DFSRH 20 Mean weekly headache index 15 10 5 Medication overuse headache is a common condition responsible for a high
More informationPDFlib PLOP: PDF Linearization, Optimization, Protection. Page inserted by evaluation version
PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version www.pdflib.com sales@pdflib.com Headache 2008 the Authors Journal compilation 2008 American Headache Society
More informationFaculty Disclosures. Learning Objectives. Acute Treatment Strategies
WWW.AMERICANHEADACHESOCIETY.ORG Acute Treatment Strategies Content developed by: Lawrence C. Newman, MD, FAHS Donna Gutterman, PharmD Faculty Disclosures LAWRENCE C. NEWMAN, MD, FAHS Dr. Newman has received
More informationThe use of combination therapies in the acute management of migraine
REVIEW The use of combination therapies in the acute management of migraine Abouch Valenty Krymchantowski Headache Center of Rio, Rio de Janeiro, Brazil; Outpatient Headache Unit of the Instituto de Neurologia
More informationConflicts of interest statements
Demographic and clinical profile of headache in a low income population at headache center in Bogotá -Colombia Marta Liliana Ramos Romero Neurologist athospital Occidente de Kennedy University of La Sabana
More informationPaediatric headaches. Dr Jaycen Cruickshank Director of Clinical Training Ballarat Health Services. Brevity, levity, repetition
Paediatric headaches Dr Jaycen Cruickshank Director of Clinical Training Ballarat Health Services Brevity, levity, repetition Paediatric)headache?)! Headache!in!children!is!not!that!common.!The!question!is!which!headaches!do!I!
More informationUpdate on Diagnosis and Management of Migraines
Update on Diagnosis and Management of Migraines Joel J. Heidelbaugh, MD, FAAFP, FACG Clinical Professor Departments of Family Medicine and Urology University of Michigan Learning Objectives To distinguish
More informationProposed Project Scope. OPTIMAL USE OnabotulinumtoxinA for the Prevention of Chronic Migraine Clinical Evidence, Policies and Practice
Proposed Project Scope OPTIMAL USE OnabotulinumtoxinA for the Prevention of Chronic Migraine Clinical Evidence, Policies and Practice May 2018 1. BACKGROUND AND RATIONALE Migraine is a common, debilitating
More informationMedication overuse headache: a critical review of end points in recent follow-up studies
J Headache Pain (2010) 11:373 377 DOI 10.1007/s10194-010-0221-4 REVIEW ARTICLE Medication overuse headache: a critical review of end points in recent follow-up studies Knut Hagen Rigmor Jensen Magne Geir
More informationAn Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California
An Overview of MOH IHS ASIAN HA MASTERS SCHOOL MARCH 24, 2013 ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California President-Elect
More information